betaxolol has been researched along with Hemolysis in 2 studies
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Liu, H | 3 |
Han, X | 1 |
Li, H | 1 |
Tao, Q | 1 |
Hu, J | 1 |
Liu, S | 1 |
Zhou, J | 1 |
Li, W | 1 |
Yang, F | 1 |
Ping, Q | 1 |
Wei, S | 1 |
Lin, H | 1 |
Hou, D | 1 |
Aoyagi, S | 1 |
Fukunaga, S | 1 |
Tayama, E | 1 |
Nakamura, E | 1 |
Egawa, N | 1 |
Hosokawa, Y | 1 |
2 other studies available for betaxolol and Hemolysis
Article | Year |
---|---|
Wettability and contact angle affect precorneal retention and pharmacodynamic behavior of microspheres.
Topics: Animals; Bentonite; Betaxolol; Cell Survival; Chemistry, Pharmaceutical; Delayed-Action Preparations | 2021 |
Benefits of a beta-blocker for intractable hemolysis due to paraprosthetic leakage.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Anemia, Hemolytic; Aspartate Aminotransferases; B | 2007 |